Telethon Kids Institute has received $2.66 million from BHP to lead a trial testing the effectiveness of multiple sclerosis drug interferon in reducing the infectiousness of COVID-19 patients.

Telethon Kids Institute has received $2.66 million from BHP to lead a trial testing the effectiveness of multiple sclerosis drug interferon in reducing the infectiousness of COVID-19 patients.